OOIR: Observatory of International Research

Papers

(The H4-Index of British Journal of Clinical Pharmacology is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
	61
Issue Information	58
Issue Highlights	56
Analysis of factors influencing the relationship between voriconazole plasma concentrations and adverse effects in a paediatric population	55
Selected Abstracts from Pharmacology 2024	54
Pharmacokinetics, safety and efficacy study in pregnancy and existing cumulative data/evidence to support clinical use and labelling of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in pre	52
Impact of codeine rescheduling on prescribing of codeine and other opioids: Interrupted time series analyses using Australian general practice data	50
Drug reaction with eosinophilia and systemic symptoms induced by paclitaxel, a rare combination	49
Case report: Dolutegravir dosing post‐Roux‐en‐Y gastric bypass surgery	49
Comparison of the Liverpool Causality Assessment Tool vs. the Naranjo Scale for predicting the likelihood of an adverse drug reaction: A retrospective cohort study	48
Letter to the editor concerning the article: ‘The impacts of undetected nonadherence in phase II, III and post‐marketing clinical trials: An overview’	48
Effect of oral clonidine on pain reduction in patients with opioid use disorder in the emergency department: A randomized clinical trial	48
Opioid‐related deaths and their counterpart by occurrence era, age group and coimplicated drugs: Scotland vs. England and Wales	47
Genetic biomarkers of methotrexate response and safety in Crohn's disease: Data from the Spanish ENEIDA registry	46
Intranasal vitamin B₁₂ administration in elderly patients: A randomized controlled comparison of two dosage regimens	42
Effects of intraoperative low‐dose esketamine on postoperative pain after vestibular schwannoma resection: A prospective randomized, double‐blind, placebo‐controlled study	40
Cardiovascular events of Bruton's tyrosine kinase inhibitors: A real‐world study based on the United States Food and Drug Administration Adverse Event Reporting System database	39
Anticholinergic deprescribing: A case report demonstrating improved cognition and function with minimal adverse withdrawal effects	39
Health technology assessment of paediatric medicines: European landscape, challenges and opportunities inside the conect4children project	36
Epidural methadone and morphine pharmacokinetics and clinical effects in healthy volunteers: A randomized, crossover‐design trial	36
Acalabrutinib CYP3A‐mediated drug–drug interactions: Clinical evaluations and physiologically based pharmacokinetic modelling to inform dose adjustment strategy	36
Incidence, clinical classification and risk factors of cyclosporin A‐induced liver injury in allogeneic haematopoietic stem cell transplant recipients	36
Design of a pharmacokinetic/pharmacodynamic model for administration of low dose peripheral norepinephrine during general anaesthesia	36
Sensitivity of estimated tacrolimus population pharmacokinetic profile to assumed dose timing and absorption in real‐world data and simulated data	35
Triple antithrombotic therapy and dual therapy – What is the evidence base?	34

Therapeutic drug monitoring of thiopurines: Effect of reduced 6‐thioguanine nucleotide target levels in inflammatory bowel disease patients	34
Pharmacokinetics, pharmacodynamics and safety assessment of multiple doses of soticlestat in healthy volunteers	34
Quantification of sertraline maternal/fetal ratio and amniotic fluid concentration using a pregnancy physiologically based pharmacokinetic model	33
Insights from a pharmacometric analysis of HDMTX in adults with cancer: Clinically relevant covariates for application in precision dosing	33
Postoperative ileus after digestive surgery: Network meta‐analysis of pharmacological intervention	32
Antidepressants are not safe during pregnancy and in women of child‐bearing age	32
Pregabalin poisoning: Evaluation of dose‐toxicity relationship	32